Literature DB >> 11391799

Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas.

J Pei1, B R Balsara, W Li, S Litwin, E Gabrielson, M Feder, J Jen, J R Testa.   

Abstract

Comparative genomic hybridization analysis was performed on 67 non-small-cell lung cancers (NSCLCs), including 32 squamous cell carcinomas (SCCs) and 35 adenocarcinomas (ACs), to identify differences in the patterns of genomic imbalance between these two histologic subtypes. Among the entire tumor set, the chromosome arms most often overrepresented were 1q, 3q, 5p, and 8q, each detected in 50-55% of cases. The most frequently underrepresented arms were 9q, 3p, 8p, and 17p. The number of imbalances was similar in SCCs and ACs (median number/case: 12 and 11, respectively). Moreover, many imbalances, such as gains of 1q, 5p, and 8q, occurred at a high frequency in both histologic subgroups. Several statistically significant differences, however, were found. The most prominent difference was gain of 3q24-qter, seen in 81% of SCCs compared with 31% of ACs (P < 0.0001), with amplification at 3q25-26 being detected in eight of 32 (25%) SCCs but in only two of 35 (6%) ACs. Gain of 20p13 and loss of 4q also were seen at a significantly higher rate in SCCs than in ACs, whereas overrepresentation of 6p was more common in ACs. Gains of 7q and 8q each were associated with higher-stage tumors and either positive nodal involvement or higher tumor grade. These data suggest that genes located in several chromosomal regions, particularly 3q25-26, may be associated with phenotypic properties that differentiate lung SCCs from ACs. Furthermore, certain imbalances, prominent among them gains of 7q and 8q, may be indicative of tumor aggressiveness in NSCLCs. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11391799     DOI: 10.1002/gcc.1145

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  28 in total

Review 1.  Genetic changes in squamous cell lung cancer: a review.

Authors:  Rebecca S Heist; Lecia V Sequist; Jeffrey A Engelman
Journal:  J Thorac Oncol       Date:  2012-05       Impact factor: 15.609

Review 2.  Pulmonary adenocarcinoma: a renewed entity in 2011.

Authors:  Humam Kadara; Mohamed Kabbout; Ignacio I Wistuba
Journal:  Respirology       Date:  2012-01       Impact factor: 6.424

3.  Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer.

Authors:  Zhe-Wei Qiu; Jia-Hao Bi; Adi F Gazdar; Kai Song
Journal:  Genes Chromosomes Cancer       Date:  2017-05-04       Impact factor: 5.006

4.  Inactivation of LLC1 gene in nonsmall cell lung cancer.

Authors:  Kyeong-Man Hong; Sei-Hoon Yang; Sinchita Roy Chowdhuri; Audrey Player; Megan Hames; Junya Fukuoka; Daoud Meerzaman; Tatiana Dracheva; Zhifu Sun; Ping Yang; Jin Jen
Journal:  Int J Cancer       Date:  2007-06-01       Impact factor: 7.396

5.  Using protein microarray as a diagnostic assay for non-small cell lung cancer.

Authors:  Li Zhong; Giovanna E Hidalgo; Arnold J Stromberg; Nada H Khattar; James R Jett; Edward A Hirschowitz
Journal:  Am J Respir Crit Care Med       Date:  2005-08-18       Impact factor: 21.405

6.  Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms.

Authors:  Xia Xu; Jennifer L Page; Jennifer A Surtees; Houchun Liu; Sarah Lagedrost; Young Lu; Roderick Bronson; Eric Alani; Alexander Yu Nikitin; Robert S Weiss
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

7.  The use of genetic markers to identify lung cancer in fine needle aspiration samples.

Authors:  Rajbir K Gill; Madeline F Vazquez; Arin Kramer; Megan Hames; Lijuan Zhang; Kerstin Heselmeyer-Haddad; Thomas Ried; Konstantin Shilo; Claudia Henschke; David Yankelevitz; Jin Jen
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

8.  DNA profiling by array comparative genomic hybridization (CGH) of peripheral blood mononuclear cells (PBMC) and tumor tissue cell in non-small cell lung cancer (NSCLC).

Authors:  Seung-Ho Baik; Bo-Keun Jee; Jin-Soo Choi; Hyoung-Kyu Yoon; Kweon-Haeng Lee; Yeul-Hong Kim; Young Lim
Journal:  Mol Biol Rep       Date:  2008-11-01       Impact factor: 2.316

9.  High frequency of genetic alterations in non-small cell lung cancer detected by multi-target fluorescence in situ hybridization.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park; So Youn Shin; Jin Man Kim; Sung Su Jung
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

10.  Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Authors:  Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.